We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+5.28%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$17.8B
AUM Growth
+$1.26B
Cap. Flow
+$567M
Cap. Flow %
3.2%
Top 10 Hldgs %
11.28%
Holding
2,904
New
221
Increased
694
Reduced
820
Closed
148

Top Buys

Rank Stock Value
1
MCK icon
McKesson
MCK
+$82.7M
2
PEP icon
PepsiCo
PEP
+$76.8M
3
MAR icon
Marriott International
MAR
+$64.8M
4
TSN icon
Tyson Foods
TSN
+$62.8M
5
PARA
Paramount Global Class B
PARA
+$52.9M

Top Sells

Rank Stock Value
1
SBUX icon
Starbucks
SBUX
+$64.8M
2
HRL icon
Hormel Foods
HRL
+$61.4M
3
GILD icon
Gilead Sciences
GILD
+$59.9M
4
HLT icon
Hilton Worldwide
HLT
+$54.7M
5
FTI icon
TechnipFMC
FTI
+$51M

Sector Composition

Rank Sector Weight
1 Technology 14.87%
2 Healthcare 14.18%
3 Financials 11.71%
4 Industrials 10.79%
5 Consumer Discretionary 10.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DGI
2151
DELISTED
DigitalGlobe Inc.
DGI
$1K ﹤0.01%
+44
New +$1.13K
WNR
2152
DELISTED
Western Refining Inc
WNR
$1K ﹤0.01%
50
-24,330
-100% -$575K
LXK
2153
DELISTED
Lexmark Intl Inc
LXK
$1K ﹤0.01%
43
-1,168
-96% -$42.5K
RPTP
2154
DELISTED
RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP
$1K ﹤0.01%
+141
New +$1K
ACCO icon
2155
Acco Brands
ACCO
$369M
– –
-185
Closed -$1K
AGD
2156
abrdn Global Dynamic Dividend Fund
AGD
$315M
– –
-2,250
Closed -$19K
AIN icon
2157
Albany International
AIN
$2.14B
– –
-41
Closed -$1K
ANF icon
2158
Abercrombie & Fitch
ANF
$4.17B
$0 ﹤0.01%
14
-52
-79% -$1K
APEI icon
2159
American Public Education
APEI
$875M
– –
-81
Closed -$2K
APVO icon
2160
Aptevo Therapeutics
APVO
$5.47M
– –
0
– –
AVD icon
2161
American Vanguard Corp
AVD
$73.5M
– –
-101
Closed -$1K
BCRX icon
2162
BioCryst Pharmaceuticals
BCRX
$2.37B
$0 ﹤0.01%
200
– –
BJRI icon
2163
BJ's Restaurants
BJRI
$1.41B
– –
-7,932
Closed -$347K
BLUE
2164
DELISTED
bluebird bio
BLUE
– –
-12
Closed -$5K
CCJ icon
2165
Cameco
CCJ
$38.3B
– –
-1,521
Closed -$16K
CCM
2166
Concord Medical Services
CCM
$18.7M
$0 ﹤0.01%
30
– –
CCRN
2167
DELISTED
Cross Country Healthcare
CCRN
– –
-21,864
Closed -$304K
CGNX icon
2168
Cognex
CGNX
$10.3B
– –
-170
Closed -$3K
CHGG icon
2169
Chegg
CHGG
$108M
$0 ﹤0.01%
+139
New +$889
CHRS icon
2170
Coherus Oncology
CHRS
$217M
$0 ﹤0.01%
+31
New +$846
CLDX icon
2171
Celldex Therapeutics
CLDX
$2.77B
– –
-47
Closed -$3K
COOP
2172
DELISTED
Mr. Cooper
COOP
$0 ﹤0.01%
11
– –
CPS icon
2173
Cooper-Standard Automotive
CPS
$504M
$0 ﹤0.01%
+10
New +$942
CRIS icon
2174
Curis
CRIS
$9.53M
– –
0
– –
CTAS icon
2175
Cintas
CTAS
$82.4B
– –
-6,168
Closed -$150K
85 86
87
88 89

Similar funds

SLAM
Swiss Life Asset Management Zurich $20.4B AUM 28.71% 1-Year Est. Return
EWA
EP Wealth Advisors Torrance, California $20.3B AUM
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return
CI Investments Inc
CI Investments Inc Toronto, Ontario, Canada $20.6B AUM 29.22% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return

Glenmede Trust's Q3 2016 Portfolio in Review

As of Q3 2016, Glenmede Trust held 2,904 positions worth $17.8B, up 7.6% from $16.5B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Glenmede Trust deployed $567M of net new capital in Q3 2016, opening 221 new positions and adding to 694 existing holdings. Its largest new stake was Horizon Therapeutics Public Limited Company Ordinary Shares: 2,050,199 shares worth $37.2M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Starbucks, an estimated $64.8M trimmed.

  • Glenmede Trust's largest Q3 2016 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 2,050,199 shares worth $37.2M.
  • Glenmede Trust added most to McKesson in Q3 2016, an estimated $82.7M increase.
  • Glenmede Trust's biggest Q3 2016 reduction was Starbucks, cutting an estimated $64.8M.
  • Glenmede Trust fully exited WILSHIRE BANCORP INC in Q3 2016, selling an estimated $18.5M.
  • Glenmede Trust's ten largest holdings make up 11% of its $17.8B portfolio in Q3 2016.
  • Glenmede Trust opened 221 new positions and closed 148 in Q3 2016.
  • Glenmede Trust's portfolio value rose 7.6% quarter-over-quarter to $17.8B.

Based on Glenmede Trust's 13F filing for Q3 2016, filed 14 Nov 2016.